News

The trial aims to compare the safety and efficacy of masitinib at 6mg/kg/day with placebo in patients with primary progressive multiple sclerosis or relapse free secondary progressive multiple

With this revised deal, Anacor has decided to give an option to GSK for extending its rights for the bacterial enzyme targeting LeuRS, as well as to add

As per the revised deal, both the parties have decided to widen the development obligation milestone for the initiation of patient dosing in a phase III pivotal trial

The tie up allows Hemispherx to manufacture and supply Alferon N Injection to physicians and patients by using Armada’s national network of specialty pharmacies. Additionally, BioRidge Pharma (BRP)

In his career, he has founded three companies, two of which went public and a third that was sold to a healthcare products company. Saloff was the co-founder

The new patent entitled, ‘Neurotherapeutic treatment for sexual dysfunction,’ includes a method to treat erectile dysfunction and premature ejaculation in males, as well as enhancing libido in females.

The trial is to investigate the efficacy, effectiveness, safety and pharmacokinetics of Posidur in 305 patients undergoing a variety of general abdominal surgical procedures. Durect expects to report

The results of the Phase 3 trial showed that the drug was well-tolerated and showed reduction in postsurgical pain over an extended period of time compared with placebo.

Heparin is used to prevent clot formation in central venous catheters and is also used as an anticoagulant (blood thinning) therapy. Heparin is availble in five new vial